Curis
CRIS
#11126
Rank
A$0.95 M
Marketcap
A$0.49
Share price
-17.89%
Change (1 day)
-80.38%
Change (1 year)

Curis (CRIS) - Cash on Hand

Cash on Hand as of March 2026 : A$21.24 Million

According to Curis's latest financial reports the company has A$21.24 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Curis - Cash on Hand chart (from 2000 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$7.55 M-76.5%
2024-12-31A$32.14 M-61.12%
2023-12-31A$82.68 M-34.28%
2022-12-31A$0.12 B-21.28%
2021-12-31A$0.15 B-27.05%
2020-12-31A$0.21 B646.83%
2019-12-31A$29.34 M-14.83%
2018-12-31A$34.45 M-55.35%
2017-12-31A$77.15 M25.01%
2016-12-31A$61.71 M-45.3%
2015-12-31A$0.11 B85.6%
2014-12-31A$60.78 M-6.8%
2013-12-31A$65.22 M22.04%
2012-12-31A$53.44 M45.29%
2011-12-31A$36.78 M-7.97%
2010-12-31A$39.96 M42.19%
2009-12-31A$28.1 M-31.27%
2008-12-31A$40.89 M-13.76%
2007-12-31A$47.42 M1.98%
2006-12-31A$46.5 M-23.04%
2005-12-31A$60.41 M-5.57%
2004-12-31A$63.98 M34.58%
2003-12-31A$47.54 M-34.63%
2002-12-31A$72.73 M-28.77%
2001-12-31A$0.10 B-23.96%
2000-12-31A$0.13 B312.85%
1999-12-31A$32.52 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
A$18.51 B 87,060.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$14.85 B 69,802.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A$79.51 M 274.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.10 B 5,081.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$0.63 B 2,909.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A$2.67 M-87.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.22 B 968.60%๐Ÿ‡บ๐Ÿ‡ธ USA